NCT00020189View on ClinicalTrials.gov

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Study Completion Date

August 31, 2004

Conditions
Head and Neck CancerThromboembolism
Interventions
DRUG

acetylsalicylic acid

DRUG

alvocidib

DRUG

clopidogrel bisulfate

Trial Locations (2)

20892

Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020189 - Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | Biotech Hunter | Biotech Hunter